Hypoxia/IL‐1α axis promotes gastric cancer progression and drug resistance
- 1 September 2017
- journal article
- Published by Wiley in Journal of Digestive Diseases
- Vol. 18 (9), 511-520
- https://doi.org/10.1111/1751-2980.12496
Abstract
The IL-1α/hypoxia axis may be a valuable target for diagnosis and treatment of GC.Keywords
This publication has 27 references indexed in Scilit:
- Review article: the epidemiology and prevention of gastric cancerAlimentary Pharmacology & Therapeutics, 2014
- Japanese gastric cancer treatment guidelines 2010 (ver. 3)Gastric Cancer, 2011
- Hypoxia and InflammationThe New England Journal of Medicine, 2011
- Inflammation and cancer: how friendly is the relationship for cancer patients?Current Opinion in Pharmacology, 2009
- Elevated Biomarkers of Inflammation Are Associated With Reduced Survival Among Breast Cancer PatientsJournal of Clinical Oncology, 2009
- Is the hypoxia-inducible factor pathway important in gastric cancer?European Journal of Cancer, 2005
- Inflammation by remote controlNature, 2005
- Molecular characterization of the tumor microenvironment in breast cancerCancer Cell, 2004
- Inflammation and cancerNature, 2002
- Hypoxia — a key regulatory factor in tumour growthNature Reviews Cancer, 2002